 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy Jazz Pharmaceuticals stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:JAZZ! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Jazz Pharmaceuticals stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult and pediatric patients with narcolepsy; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; and Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia. The company also offers JZP-258, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for some narcolepsy patients; JZP-385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP-458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and lurbinectedin, a product candidate under clinical investigation for the treatment of patients with relapsed small cell lung cancer. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc . The company was founded in 2003 and is headquartered in Dublin, Ireland.
Volume médio
809,967 shs
MERCADO CAP
$8.97 billion
Bolsa de Valores
NASDAQ
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NASDAQ:JAZZ
|
Preparações farmacêuticas
|
Médico
|
13,357 shs
|
Below is a quick guide on how to buy NASDAQ:JAZZ stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy Jazz Pharmaceuticals shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy Jazz Pharmaceuticals – Search for “”NASDAQ:JAZZ”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Jazz Pharmaceuticals stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
18 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Jazz Pharmaceuticals in the last twelve months. There are currently 1 sell rating, 1 hold rating and 16 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Jazz Pharmaceuticals stock.
Wall Street analysts have given Jazz Pharmaceuticals a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Jazz Pharmaceuticals wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:JAZZ stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Jazz Pharmaceuticals stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Jazz Pharmaceuticals stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NASDAQ:JAZZ stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NASDAQ:JAZZ stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:JAZZ is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Jazz Pharmaceuticals stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Jazz Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, February 23rd 2021.
View our earnings forecast for Jazz Pharmaceuticals.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced its quarterly earnings data on Monday, November, 2nd. The specialty pharmaceutical company reported $4.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.08 by $0.23. The specialty pharmaceutical company had revenue of $600.90 million for the quarter, compared to analyst estimates of $577.62 million. Jazz Pharmaceuticals had a net margin of 7.86% and a trailing twelve-month return on equity of 20.16%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same period in the previous year, the business posted $4.10 EPS.
View Jazz Pharmaceuticals’ earnings history.
Jazz Pharmaceuticals’ stock was trading at $108.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, JAZZ shares have increased by 49.0% and is now trading at $161.00.
18 brokerages have issued 1-year price targets for Jazz Pharmaceuticals’ stock. Their forecasts range from $128.00 to $233.00. On average, they expect Jazz Pharmaceuticals’ stock price to reach $175.50 in the next twelve months. This suggests a possible upside of 9.0% from the stock’s current price.
View analysts’ price targets for Jazz Pharmaceuticals or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:JAZZ stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
Jazz Pharmaceuticals’ management team includes the following people:
Mr. Bruce C. Cozadd, Co-Founder, Chairman & CEO (Age 57, Pay $2.33M)
Mr. Daniel N. Swisher Jr., Pres & COO (Age 58, Pay $1.24M)
Ms. Neena M. Patil J.D., Sr. VP & Gen. Counsel (Age 46, Pay $331.61k)
Dr. Robert Iannone M.D., Exec. VP of R&D and Chief Medical Officer (Age 53, Pay $771.48k)
Ms. Renée D. Galá, Exec. VP & CFO (Age 49)
Ms. Patricia Carr, VP of Fin. & Principal Accounting Officer (Age 50)
Dr. Finbar Larkin Ph.D., Sr. VP of Technical Operations (Age 63)
Dr. Katherine A. Littrell, VP of Investor Relations
Mr. George Eliades Ph.D., Sr. VP of Corp. Devel. & Chief Transformation Officer
Ms. Heidi Manna, Sr. VP & Chief HR Officer
60 employees have rated Jazz Pharmaceuticals CEO Bruce C. Cozadd on Glassdoor.com. Bruce C. Cozadd has an approval rating of 92% among Jazz Pharmaceuticals’ employees. This puts Bruce C. Cozadd in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Some companies that are related to Jazz Pharmaceuticals include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of JAZZ’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Jazz Pharmaceuticals investors own include Ligand Pharmaceuticals (LGND), Gilead Sciences (GILD), Alibaba Group (BABA), Micron Technology (MU), NVIDIA (NVDA), Netflix (NFLX), Tesla (TSLA), AbbVie (ABBV), Bank of America (BAC) and Biogen (biib).
Jazz Pharmaceuticals trades on the NASDAQ under the ticker symbol “JAZZ.”
Jazz Pharmaceuticals’ stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.48%), Boston Partners (1.75%), Robeco Institutional Asset Management B.V. (0.42%), Rhenman & Partners Asset Management AB (0.39%), Swiss National Bank (0.38%) and Jennison Associates LLC (0.36%). Company insiders that own Jazz Pharmaceuticals stock include Bruce C Cozadd, Catherine A Sohn, Finbar Larkin, Kenneth W O’keefe, Matthew P Young, Michael Patrick Miller, Patricia Carr, Patrick G Enright, Paul L Berns, Paul Treacy, Seamus Mulligan and Suzanne Sawochka Hooper.
View institutional ownership trends for Jazz Pharmaceuticals.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
JAZZ stock was sold by a variety of institutional investors in the last quarter, including AJO LP, First Trust Advisors LP, Russell Investments Group Ltd., Robeco Institutional Asset Management B.V., PGGM Investments, Zurcher Kantonalbank Zurich Cantonalbank, Wedge Capital Management L L P NC, and AMF Pensionsforsakring AB. Company insiders that have sold Jazz Pharmaceuticals company stock in the last year include Bruce C Cozadd, Finbar Larkin, Michael Patrick Miller, Patricia Carr, Patrick G Enright, and Paul L Berns.
View insider buying and selling activity for Jazz Pharmaceuticals or view top insider-selling stocks.
JAZZ stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Jennison Associates LLC, Rhenman & Partners Asset Management AB, Nisa Investment Advisors LLC, Highland Capital Management LLC, SG Americas Securities LLC, Kornitzer Capital Management Inc. KS, and Victory Capital Management Inc..
View insider buying and selling activity for Jazz Pharmaceuticals or or view top insider-buying stocks.
Shares of JAZZ can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of JAZZ stock can currently be purchased for approximately $161.00.
Jazz Pharmaceuticals has a market capitalization of $8.97 billion and generates $2.16 billion in revenue each year. The specialty pharmaceutical company earns $523.37 million in net income (profit) each year or $14.60 on an earnings per share basis.
Jazz Pharmaceuticals employs 1,620 workers across the globe.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy Jazz Pharmaceuticals stock on the internet?
You can easily buy Jazz Pharmaceuticals stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading NASDAQ:JAZZ stocks in a safe and complete environment to trade in.
Where to buy Jazz Pharmaceuticals stock?
You will first want to find a licensed broker that supports NASDAQ:JAZZ stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:JAZZ stocks in a safe and complete environment.
Is NASDAQ:JAZZ stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:JAZZ stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Jazz Pharmaceuticals stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:JAZZ is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Jazz Pharmaceuticals stock.
How do you trade Jazz Pharmaceuticals stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Jazz Pharmaceuticals stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:JAZZ stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Jazz Pharmaceuticals stock?
To sell your NASDAQ:JAZZ stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Jazz Pharmaceuticals stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:JAZZ stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Bolsa de Valores de Paris (EPA)
Todas as ações da EPA Mais informações Ações da EPA O que é a Bolsa de Valores de Paris (EPA)? Agora
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
